s6y
Company name or ticker
Search
Veraxa Biotech AG - Post de-SPAC
3
von Halem Carl: Initial statement of beneficial ownership of securities
Filed
Thursday, August 20, 2026
Period
Jul 10, 2026
Accession number
0001829126-26-009154
Documents
FORM 3
3
On sec.gov
Filing index
All files
Complete submission text
SGML header